<VariationArchive VariationID="973235" VariationName="NM_130837.3(OPA1):c.2287del (p.Ser763fs)" VariationType="Deletion" Accession="VCV000973235" Version="14" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-07-29" DateCreated="2020-07-25" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="961599" VariationID="973235">
      <GeneList>
        <Gene Symbol="OPA1" FullName="OPA1 mitochondrial dynamin like GTPase" GeneID="4976" HGNC_ID="HGNC:8140" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3q29</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="193593208" stop="193697811" display_start="193593208" display_stop="193697811" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="193310932" stop="193415599" display_start="193310932" display_stop="193415599" Strand="+" />
          </Location>
          <OMIM>605290</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_130837.3(OPA1):c.2287del (p.Ser763fs)</Name>
      <CanonicalSPDI>NC_000003.12:193657185:AAA:AA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3q29</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="193657186" stop="193657186" display_start="193657186" display_stop="193657186" variantLength="1" positionVCF="193657185" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="193374975" stop="193374975" display_start="193374975" display_stop="193374975" variantLength="1" positionVCF="193374974" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>S584fs</ProteinChange>
      <ProteinChange>S585fs</ProteinChange>
      <ProteinChange>S672fs</ProteinChange>
      <ProteinChange>S690fs</ProteinChange>
      <ProteinChange>S708fs</ProteinChange>
      <ProteinChange>S709fs</ProteinChange>
      <ProteinChange>S726fs</ProteinChange>
      <ProteinChange>S727fs</ProteinChange>
      <ProteinChange>S745fs</ProteinChange>
      <ProteinChange>S763fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.193374977del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.193374977del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.193657188del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.193657188del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011605.1" sequenceAccession="NG_011605" sequenceVersion="1" change="g.69045del">
            <Expression>NG_011605.1:g.69045del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354663.2" sequenceAccession="NM_001354663" sequenceVersion="2" change="c.1753del">
            <Expression>NM_001354663.2:c.1753del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341592.1" sequenceAccession="NP_001341592" sequenceVersion="1" change="p.Ser585fs">
            <Expression>NP_001341592.1:p.Ser585fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354664.2" sequenceAccession="NM_001354664" sequenceVersion="2" change="c.1750del">
            <Expression>NM_001354664.2:c.1750del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341593.1" sequenceAccession="NP_001341593" sequenceVersion="1" change="p.Ser584fs">
            <Expression>NP_001341593.1:p.Ser584fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015560.3" sequenceAccession="NM_015560" sequenceVersion="3" change="c.2122del">
            <Expression>NM_015560.3:c.2122del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_056375.2" sequenceAccession="NP_056375" sequenceVersion="2" change="p.Ser708fs">
            <Expression>NP_056375.2:p.Ser708fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130831.3" sequenceAccession="NM_130831" sequenceVersion="3" change="c.2014del">
            <Expression>NM_130831.3:c.2014del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_570844.1" sequenceAccession="NP_570844" sequenceVersion="1" change="p.Ser672fs">
            <Expression>NP_570844.1:p.Ser672fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130832.3" sequenceAccession="NM_130832" sequenceVersion="3" change="c.2068del">
            <Expression>NM_130832.3:c.2068del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_570845.1" sequenceAccession="NP_570845" sequenceVersion="1" change="p.Ser690fs">
            <Expression>NP_570845.1:p.Ser690fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130833.3" sequenceAccession="NM_130833" sequenceVersion="3" change="c.2125del">
            <Expression>NM_130833.3:c.2125del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_570846.1" sequenceAccession="NP_570846" sequenceVersion="1" change="p.Ser709fs">
            <Expression>NP_570846.1:p.Ser709fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130834.3" sequenceAccession="NM_130834" sequenceVersion="3" change="c.2176del">
            <Expression>NM_130834.3:c.2176del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_570847.2" sequenceAccession="NP_570847" sequenceVersion="2" change="p.Ser726fs">
            <Expression>NP_570847.2:p.Ser726fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130835.3" sequenceAccession="NM_130835" sequenceVersion="3" change="c.2179del">
            <Expression>NM_130835.3:c.2179del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_570848.1" sequenceAccession="NP_570848" sequenceVersion="1" change="p.Ser727fs">
            <Expression>NP_570848.1:p.Ser727fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130836.3" sequenceAccession="NM_130836" sequenceVersion="3" change="c.2233del">
            <Expression>NM_130836.3:c.2233del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_570849.2" sequenceAccession="NP_570849" sequenceVersion="2" change="p.Ser745fs">
            <Expression>NP_570849.2:p.Ser745fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130837.3" sequenceAccession="NM_130837" sequenceVersion="3" change="c.2287del" MANESelect="true">
            <Expression>NM_130837.3:c.2287del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_570850.2" sequenceAccession="NP_570850" sequenceVersion="2" change="p.Ser763fs">
            <Expression>NP_570850.2:p.Ser763fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_337" sequenceAccession="LRG_337">
            <Expression>LRG_337:g.69045del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_337t2" sequenceAccession="LRG_337t2">
            <Expression>LRG_337t2:c.2287del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_337t1" sequenceAccession="LRG_337t1">
            <Expression>LRG_337t1:c.2122del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015560.2" sequenceAccession="NM_015560" sequenceVersion="2" change="c.2122delA">
            <Expression>NM_015560.2:c.2122delA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1219753329" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_130837.3(OPA1):c.2287del (p.Ser763fs) AND multiple conditions" Accession="RCV001249637" Version="5">
        <ClassifiedConditionList TraitSetID="55771">
          <ClassifiedCondition DB="MedGen" ID="C0221061">Abortive cerebellar ataxia</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0338508">Autosomal dominant optic atrophy classic form</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3276549">Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-09-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_130837.3(OPA1):c.2287del (p.Ser763fs) AND not provided" Accession="RCV001587285" Version="8">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-10-19" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_130837.3(OPA1):c.2287del (p.Ser763fs) AND OPA1-related disorder" Accession="RCV004538529" Version="1">
        <ClassifiedConditionList TraitSetID="74782">
          <ClassifiedCondition>OPA1-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-09-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-19" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2020-07-25" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11440988</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20157015</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20952381</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21036400</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25012220</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32371413</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="55771" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3314" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy</ElementValue>
                <XRef ID="MONDO:0007429" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15057" />
                <XRef ID="15057" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C3276549" DB="MedGen" />
              <XRef ID="MONDO:0007429" DB="MONDO" />
              <XRef Type="MIM" ID="125250" DB="OMIM" />
            </Trait>
            <Trait ID="591" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Abortive cerebellar ataxia</ElementValue>
                <XRef ID="66988006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">OPTIC ATROPHY, INFANTILE HEREDITARY, WITH NEUROLOGIC ABNORMALITIES</ElementValue>
                <XRef Type="MIM" ID="210000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Behr syndrome</ElementValue>
                <XRef ID="MONDO:0008858" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Optic atrophy, infantile hereditary, Behr complicated form of</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Optic atrophy in early childhood, associated with ataxia, spasticity, mental retardation, and posterior column sensory loss</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BEHRS</ElementValue>
                <XRef Type="MIM" ID="210000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="849" />
                <XRef ID="849" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29517884</ID>
                <ID Source="BookShelf">NBK487393</ID>
              </Citation>
              <XRef ID="1239" DB="Orphanet" />
              <XRef ID="C0221061" DB="MedGen" />
              <XRef ID="MONDO:0008858" DB="MONDO" />
              <XRef Type="MIM" ID="210000" DB="OMIM" />
            </Trait>
            <Trait ID="5679" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Optic atrophy, juvenile</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Kjer-type optic atrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal dominant optic atrophy classic form</ElementValue>
                <XRef ID="717336005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Optic Atrophy Type 1</ElementValue>
                <XRef ID="NBK1248" DB="GeneReviews" />
                <XRef ID="Optic+atrophy+1/5380" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OPA1</ElementValue>
                <XRef Type="MIM" ID="165500" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">OAK</ElementValue>
                <XRef Type="MIM" ID="165500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Optic atrophy type 1 (OPA1, or Kjer type optic atrophy) is characterized by bilateral and symmetric optic nerve pallor associated with insidious decrease in visual acuity (usually between ages 4 and 6 years), visual field defects, and color vision defects. Visual impairment is usually moderate (6/10 to 2/10), but ranges from mild or even insignificant to severe (legal blindness with acuity &lt;1/20). The visual field defect is typically centrocecal, central, or paracentral; it is often large in those with severe disease. The color vision defect is often described as acquired blue-yellow loss (tritanopia). Other findings can include auditory neuropathy resulting in sensorineural hearing loss that ranges from severe and congenital to subclinical (i.e., identified by specific audiologic testing only). Visual evoked potentials are typically absent or delayed; pattern electroretinogram shows an abnormal N95:P50 ratio. Tritanopia is the classic feature of color vision defect, but more diffuse nonspecific dyschromatopsia is not uncommon. Ophthalmoscopic examination discloses temporal or diffuse pallor of the optic discs, sometimes associated with optic disc excavation. The neuroretinal rim shows some pallor in most cases, sometimes associated with a temporal pigmentary gray crescent.</Attribute>
                <XRef ID="NBK1248" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9890" />
                <XRef ID="9890" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="98673" DB="Orphanet" />
              <XRef ID="C0338508" DB="MedGen" />
              <XRef ID="MONDO:0008134" DB="MONDO" />
              <XRef Type="MIM" ID="165500" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="74782" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="62430" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">OPA1-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OPA1-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OPA1 related disorders</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2807009" SubmissionDate="2020-05-21" DateLastUpdated="2020-07-25" DateCreated="2020-07-25">
        <ClinVarSubmissionID localKey="NCH:2516|OMIM:210000;165500;125250" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001423604" DateUpdated="2020-07-25" DateCreated="2020-07-25" Type="SCV" Version="1" SubmitterName="Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital" OrgID="196472" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-09-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>[ACMG/AMP: PVS1, PM2] This alteration is a null variant in a gene where LOF is a known mechanism of disease [PVS1], is absent from or rarely observed in large-scale population databases [PM2].</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_130837.2:c.2287delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="210000" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="165500" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="125250" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7483583</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3564772" SubmissionDate="2021-09-02" DateLastUpdated="2021-09-08" DateCreated="2021-09-08">
        <ClinVarSubmissionID localKey="GDXSV:60471" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001822388" DateUpdated="2021-09-08" DateCreated="2021-09-08" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-10-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at a significant frequency in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 32371413, 21036400)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA1" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:643759</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015560.2:c.2122delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_29_20210901092436</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5419048" SubmissionDate="2022-12-27" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="A17882|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002771115" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Athena Diagnostics" OrgID="1012" OrganizationCategory="laboratory" OrgAbbreviation="ADX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">32371413</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21036400</ID>
          </Citation>
          <Comment>This variant is expected to result in the loss of a functional protein. The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). This variant has been identified in at least one individual with clinical features associated with this gene. In some published literature, this variant is referred to as c.2287delA, p.(Ser763ValfsTer15).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Athena Diagnostics Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015560.2:c.2122del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12478070</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7696294" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="3554399|OPA1-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004119705" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The OPA1 c.2287delA variant is predicted to result in a frameshift and premature protein termination (p.Ser763Valfs*15). This variant has been reported in the heterozygous state in an individual with optic neuropathy (reported as c.2122del in Yu-Wai-Man et al. 2011. PubMed ID: 21036400). This variant is reported in 0.00088% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/3-193374974-GA-G). Frameshift variants in OPA1 are expected to be pathogenic, and this variant has been interpreted as pathogenic by multiple independent submitters to the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/variation/973235). Given the evidence, we too interpret c.2287del (p.Ser763Valfs*15) as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_130837.2:c.2287delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">OPA1-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4258852" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4848330|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002239002" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11440988</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20157015</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20952381</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25012220</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21036400</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ser708Valfs*15) in the OPA1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in OPA1 are known to be pathogenic (PMID: 11440988, 20157015, 20952381, 25012220). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with autosomal dominant optic atrophy (PMID: 21036400). ClinVar contains an entry for this variant (Variation ID: 973235). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.193374975del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4258852" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3564772" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2807009" TraitType="Disease" MappingType="XRef" MappingValue="125250" MappingRef="OMIM">
        <MedGen CUI="C3276549" Name="Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5419048" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2807009" TraitType="Disease" MappingType="XRef" MappingValue="165500" MappingRef="OMIM">
        <MedGen CUI="C0338508" Name="Autosomal dominant optic atrophy classic form" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7696294" TraitType="Disease" MappingType="Name" MappingValue="OPA1-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="OPA1-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2807009" TraitType="Disease" MappingType="XRef" MappingValue="210000" MappingRef="OMIM">
        <MedGen CUI="C0221061" Name="Abortive cerebellar ataxia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

